Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-61,980
Closed -$150K 13825
2026
Q1
$150K Sell
61,980
-154,343
-71% -$421K ﹤0.01% 12003
2025
Q4
$943K Buy
216,323
+163,940
+313% +$886K ﹤0.01% 7326
2025
Q3
$220K Buy
+52,383
New +$186K ﹤0.01% 10788
2025
Q2
Sell
-157,331
Closed -$416K 13040
2025
Q1
$425K Buy
+157,331
New +$590K ﹤0.01% 9270
2024
Q4
Sell
-41,432
Closed -$98.2K 12586
2024
Q3
$98.2K Sell
41,432
-32,426
-44% -$71.4K ﹤0.01% 11063
2024
Q2
$144K Buy
+73,858
New +$251K ﹤0.01% 10732

Other funds holding GNLX

Jeff Yass's GNLX Position: Q2 2026 in Review

Jeff Yass sold out of Genelux (GNLX) in Q2 2026, closing a stake of 61,980 shares — an estimated $150K sold.

Jeff Yass first reported a position in GNLX in Q2 2024 and held it in 6 quarters. The position peaked at $943K in Q4 2025. 72 funds tracked by Wall St. Rank hold GNLX as of Q2 2026.

  • Jeff Yass reported no remaining Genelux position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 61,980 Genelux shares in Q2 2026, an estimated $150K.
  • Jeff Yass first reported a position in Genelux in Q2 2024 and held it in 6 quarters.
  • Jeff Yass's Genelux position peaked at $943K in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Genelux as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.